瘤微环境与对跨动脉和全身治疗的耐药性之间的相互作用
Maria Stella Franzè1, Francesca Saffioti2,3,4, Vasileios K Mavroeidis5,6
1Department of Clinical and Experimental Medicine, University of Messina, Messina 98124, Italy.
Cancer drug resistance (Alhambra, Calif.)
|August 22, 2025
概括
肝细胞癌 (HCC) 是一种致命的肝癌. 向瘤微环境 (TME) 和调节免疫反应有望改善患者的治疗结果并克服治疗抵抗力.
科学领域:
- 癌症学
- 免疫学
- 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌,通常由慢性炎症和纤维化引起.
- 肝硬化是HCC的主要危险因素,强调了早期检测的必要性.
- 尽管治疗取得了进展,但HCC的存活率仍然很低,这凸显了未得到满足的临床需求.
研究的目的:
- 审查瘤微环境 (TME) 在HCC发展和进展中的关键作用.
- 探索TME如何影响HCC的免疫逃避和治疗阻力.
- 讨论目前和新兴的针对TME的策略,以提高HCC治疗效率.
主要方法:
- 对HCC,瘤微环境和免疫疗法的文献综述.
- 对HCC TME的细胞和分子组件的分析.
- 针对TME的治疗策略的综合证据.
主要成果:
- TME包括免疫细胞,纤维细胞和细胞外基质,显著影响瘤的行为.
- 在TME内的特定免疫细胞促进免疫抑制和HCC的进展.
- 针对TME,特别是通过免疫调节,显示出增强治疗反应的潜力.
结论:
- 在HCC的发病,免疫规避和治疗耐药性方面,TME起着关键作用.
- 针对TME的免疫调节策略是HCC的有希望的治疗途径.
- 涉及TME调制的组合疗法可以改善HCC患者的临床结果.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.4K
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.3K
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
